|
HERPUD2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62436730732907E-12 |
| Normal-vs-Stage2 |
8.86250000053934E-07 |
| Normal-vs-Stage3 |
4.34360000189926E-08 |
| Normal-vs-Stage4 |
3.34069999996522E-06 |
| Stage1-vs-Stage2 |
4.734200E-01 |
| Stage1-vs-Stage3 |
1.376470E-03 |
| Stage1-vs-Stage4 |
2.142900E-03 |
| Stage2-vs-Stage3 |
1.269560E-01 |
| Stage2-vs-Stage4 |
1.020010E-01 |
| Stage3-vs-Stage4 |
7.797200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.11022302462516E-16 |
| Normal-vs-AfricanAmerican |
5.219300E-04 |
| Normal-vs-Asian |
4.579600E-02 |
| Caucasian-vs-AfricanAmerican |
2.842300E-02 |
| Caucasian-vs-Asian |
5.144400E-01 |
| AfricanAmerican-vs-Asian |
1.290030E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.22044604925031E-15 |
| Normal-vs-Female |
1.62436730732907E-12 |
| Male-vs-Female |
1.232210E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.463400E-03 |
| Normal-vs-Age(41-60Yrs) |
1.62470037423645E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62470037423645E-12 |
| Normal-vs-Age(81-100Yrs) |
9.362400E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.600200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.601400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.281400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.676400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.522000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.153600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.39359999999867E-05 |
| Normal-vs-Grade 2 |
1.62436730732907E-12 |
| Normal-vs-Grade 3 |
1.35940148027203E-11 |
| Normal-vs-Grade 4 |
1.082340E-03 |
| Grade 1-vs-Grade 2 |
4.522200E-02 |
| Grade 1-vs-Grade 3 |
4.424700E-04 |
| Grade 1-vs-Grade 4 |
8.02510000000867E-05 |
| Grade 2-vs-Grade 3 |
1.793770E-04 |
| Grade 2-vs-Grade 4 |
2.03099999999123E-05 |
| Grade 3-vs-Grade 4 |
8.278300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
<1E-12 |
| Normal-vs-ccB subtype |
5.25569999965114E-07 |
| ccA subtype-vs-ccB subtype |
7.69384556065233E-14 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.62436730732907E-12 |
| Normal-vs-N1 |
1.520630E-01 |
| N0-vs-N1 |
1.265810E-01 |
|
|
